HealthTech / Life Sciences Investors in Toronto

Focuses on emerging growth companies primarily in financial services, technology, and resource sectors, providing private equity, private debt, and venture capital.

Invests in small and medium-sized Canadian companies in the business and healthcare services and telecom industries.

North American private equity firm focused on selectively acquiring significant interests in high-quality businesses with meaningful growth potential, primarily in services sub-sectors.

Early-stage impact venture fund focused on transformational technology in Climate and Health solutions.

Toronto-based $35MM venture capital fund founded in 2022 investing in early-stage startups across AI, fintech, SaaS, healthcare, and cleantech across North America and internationally.

Leading Canadian mid-market private equity firm with 5 funds raised and 36 deals recorded.

BMO's technology and innovation banking group launched in 2019 providing venture debt and growth financing to Canadian tech companies. Expanded aggressively post-SVB to capture market share.

Company creation studio that builds, buys and makes seed-stage investments in disruptive consumer products.

Companies advancing healthy aging, brain health, and dementia care.

Strategic advice, cash management, and flexible capital solutions to innovation companies. Financing from $1M to $100M+.

Leading Canadian mid-market PE firm investing through buyouts, growth and acquisition financings since 2002.

Founder-friendly PE firm focusing on lower mid-market businesses with a focus on generational transitions and succession planning.

Invest in early-stage B2B enterprise software companies with clear product-market fit and strong Canadian angle.

Award-winning commercialization venture firm building companies with entrepreneurs to accelerate oncology innovation, partnered with the Ontario Institute for Cancer Research (OICR).

Investment management firm specializing in infrastructure and real estate, a subsidiary of Fengate Corporation operating since 1974.

Early stage, emerging and growth-oriented enterprise software companies. Dedicated Enterprise software focus.

Publicly listed provider of flexible growth and alternative capital, supporting revenue-generating, VC-backed, and founder-owned companies seeking growth capital with minimal dilution.

Active capital model in AI-powered vertical SaaS. Focus on proven product-market fit and compelling unit economics.

CoFounds & Funds B2B AI-native SaaS companies with values-driven leaders.

Early-stage life science opportunities in areas of unmet medical need. Company co-creation investment strategy.

Toronto-based growth capital firm founded in 2008, one of Canada's largest investment firms, investing in enterprise software and internet companies with nearly $3B raised across 5 growth funds.

Leading seed-stage venture capital fund based in Toronto, investing across North America with 7 funds raised and 140 deals recorded.

Canada's seed stage VC partner for exceptional B2B founders. Focus on capital efficiency and global scaling.

Growth capital investment firm providing private funding and merchant banking services to a wide variety of businesses at different stages of development.

Toronto-based private equity fund manager focused on buyout opportunities in the Canadian and American mid-market.

JPMorgan's Canadian innovation economy unit expanding aggressively with 5 dedicated tech bankers. Hired Scotiabank's former head of TIB (David Rozin) to lead Canadian expansion, picking up hundreds of

MedTech and Digital Health companies improving patient outcomes and expanding access to care.

Leading North American healthcare VC building transformative biotechnology and medical device companies.

Bridges a critical gap in early-stage funding, catalyzing later-stage funding for promising technology companies across enterprise software, health tech, clean tech and deep tech.

One of Canada's most active private markets investors for over two decades. $28B USD in AUM across 10 global offices.

Making private equity investments since 1987 on behalf of OMERS, one of Canada's largest pension plans with over $60.8B in assets; manages over $6.5B globally.

Founded in 1984, one of Canada's oldest private equity firms committed to acquiring and building high-quality businesses in partnership with talented management teams.

Toronto-based middle-market private equity firm with 4 funds and 235 deals recorded, primarily in healthcare, financial, and business services.

Founded in 1994, Toronto-based private equity firm managing several portfolios with assets of $85M.

Canada-Silicon Valley Series A venture fund concentrating on investments just before scaling begins, with 2 funds and 8 deals recorded.

Backer of Canada's most daring innovators and idea generators; RBC's technology growth banking and venture arm.

Early-stage VC focused on companies developing creator and developer tools and enterprise software across software, cloud, health tech, crypto, and fintech.

Private venture capital and mutual fund management company with 1 fund and 51 deals recorded.

Scotiabank's tech lending arm with ~C$2B lent to Canadian tech companies including BenchSci, Helcim, GeoComply, and Field Effect. Launched in 2019, expanded post-SVB collapse. Also operates via subsid

Global investment firm with $620M+ USD in AUM. Partners with visionary founders across technology and healthcare. Fund III closed at $338M CAD.

Lead seed-stage rounds into B2B software companies. Five-pillar Founder Growth Platform.

Toronto-based early-stage VC fund investing in high-growth technology startups led or co-led by women founders, backing globally competitive companies across enterprise software, digital health, and f

Venture banking division of Stifel providing venture debt ($1M-$50M+), treasury management, and capital raising for seed through IPO-stage tech companies. Over 100 bankers, $10B+ in loan commitments.